Eli Lilly & Co. (NYSE:LLY)
CAPS Rating:
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
Recs
5% divy, sustainable payout ratio (45% according to Yahoo! Finance), MFI stats from MagicDiligence.com:Results for ticker 'LLY' (Eli Lilly and Company):Earnings Yield: 16.1%MFI Return on Capital: 48.2%MagicDiligence Research for 'LLY':Research Available for LLY!Instant Diligence:The Earnings Yield of 16.1% is Very High.The MFI Return on Capital of 48.2% is High.Near-term Financial Health appears to be Excellent. The current ratio is 2.01.Calculations:(for quarter ended 2011-03-31)Market Cap = Stock_Price * Shares = 38.08 * 1112.00 = 42344.96Excess Cash = Cash - MAX(0; (Current Liabilities - Current Assets + Cash)) = 6713.10 - MAX(0; (7651.80 - 15354.30 + 6713.10)) = 6713.10Enterprise Value = Market Cap + Total Debt - Excess Cash = 42344.96 + 6672.30 - 6713.10 = 42304.16MFI Invested Capital = Total Assets - Goodwill - Intangibles - Current Liabilities + Short Term Debt - Excess Cash = 31695.30 - 0.00 - 4731.30 - 7651.80 + 1539.90 - 6713.10 = 14139.00Earnings Yield = Operating Earnings / Enterprise Value = 6812.10 / 42304.16 = 0.161 (16.1%)MFI Return on Capital = Operating Earnings / MFI Invested Capital = 6812.10 / 14139.00 = 0.482 (48.2%)